BrightFocus Foundation’s next Zoom In on Dementia & Alzheimer’s episode will feature neurologist Dr. James E. Galvin to discuss Lewy body dementia. Topics include: Early warning signs, how it differs from Alzheimer’s, current and emerging treatment options & more. Register: https://bit.ly/4r1ycw4

BrightFocus Foundation's National Glaucoma Research has just awarded 16 new research grants totaling $2.3 million to support scientists dedicated to preventing, treating, and curing glaucoma. Meet this exceptional group of vision science innovators moving us closer to a cure: https://bit.ly/3TkVC2V

The FDA just approved Leqembi® as an at-home injection starting at the beginning of treatment. This means early-stage Alzheimer's treatment can now begin and continue outside the clinic. Fewer trips, more flexibility, same safety/efficacy profile as IV infusions. Read more: https://bit.ly/4w5KzJl

7.2 million Americans over 65 are living with Alzheimer's, and the disease starts affecting the brain long before symptoms show. Early detection gives people and families more options. If you or someone you love is experiencing memory changes, talk to a doctor. Learn more: https://bit.ly/4pEmzLj

Proud to partner with Alzheimer's Los Angeles to fund teams at UCLA & USC who are using AI to: → Track ‘jumping genes’ linked to disease & explore RNA therapies → Design drug candidates to block toxic tau protein buildup Explore the research: LINK Find out more. ↘️

BrightFocus Foundation, Alzheimer's LA Fund New AI-Driven Alzheimer's Research

Early-stage pilot grants aim to accelerate innovation and collaboration in Southern California.

brightfocus.org

Agitation is a common and difficult symptom of Alzheimer's, affecting the entire family. Dr. Brent Forester joins us to explain what's behind it and how it can look different from person to person. Watch live tomorrow at 1 p.m. ⤵️ https://www.youtube.com/live/KpEKCc33Ovc

Agitation in Alzheimer’s Dementia

YouTube video by BrightFocus Foundation

youtube.com

Did you know your daily habits could be protecting your eyes without you even realizing it? Dr. Joshua Dunaief breaks down exactly what to eat, actions to take, and what to avoid. Watch more: https://bit.ly/4vPIGQM

🎙️ Introducing Let’s Talk Alzheimer’s—a new podcast from BrightFocus Foundation’s Alzheimer’s Disease Research program. Listen to our first episodes and subscribe wherever you get your podcasts: https://bit.ly/3PSMzoM.

In recognition of Healthy Vision Month, Amy D. Zhang, MD, of the University of Michigan Kellogg Eye Center joins our Glaucoma Chat to discuss what scientists are learning about nutrients, caffeine, alcohol, and eye health. Live at 1 pm ET: BrightFocus.org/livechatNGR

Nearly 1 in 3 people who take corticosteroids experience elevated eye pressure, a major glaucoma risk factor. BrightFocus-funded scientist Daniel Stamer, PhD, is zeroing in on the gene that may be behind it. 🔎

Understanding the Causes of Steroid-Induced Glaucoma

A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.

brightfocus.org

Tomorrow's Macular Chat will stream live at 1:00 p.m. ET! Kapil Bharti, PhD, will join us to explore whether cell therapy could one day repair or replace damaged retinal cells in macular degeneration and what the science looks like right now. Listen live. ↘️ BrightFocus.org/livechatMDR

Macular Chats - Live Audio Stream

Tune into live audio sessions with vision experts discussing macular degeneration care, treatment, and patient questions.

brightfocus.org

Can TV be genuinely supportive for someone living with dementia? On April 23, Allyson Schrier joins us to share how research following her experience caring for her husband with dementia led her to create Zinnia TV, a streaming service designed to engage people living with memory loss. Register ↘️

Zoom In on Dementia & Alzheimer's

Join us for live, interactive conversations with world-class expert scientists to discuss research, treatments, and practical advice for managing Alzheimer’s disease and other types of dementia.

bit.ly

Glaucoma doesn’t impact all communities equally. Dr. Victoria Tseng joins us live today, April 8 at 1pm ET, to discuss the latest research on glaucoma disparities, cultural and healthcare barriers, and the importance of early screening to help protect vision. Listen now: BrightFocus.org/livechatNGR

📸: A 3D rendering of a retinal ganglion cell—the neurons that carry visual signals from your eye to your brain. Dr. Rob Nickells, a BrightFocus Foundation National Glaucoma Research grant recipient, is studying how to protect these cells from glaucoma. https://bit.ly/4tGjBHK

Scientists are developing a new pill-based Alzheimer’s treatment that targets a different pathway than the medications already on the market. Read about this and more top Alzheimer's headlines in our Breaking News Dispatch, supported by sponsorship funding from Lilly: https://bit.ly/41c8HfG.

Join us today as Dr. Michael Detke shares details about the SPRING trial studying an investigational oral drug aimed at reducing brain damage linked to the gum‑disease bacteria P. gingivalis. We'll also outline who may qualify & what participation looks like. youtube.com/live/y2o7wtfOSX8

The SPRING Trial: Targeting Gum Bacteria in Alzheimer's

Emerging science suggests that the bacteria P. gingivalis--which is associated with gum disease--may play a role in Alzheimer's disease. In this episode, Dr. Michael J. Detke of Lighthouse Pharma explains the SPRING clinical trial and how the investigat...

youtube.com

In recognition of National Minority Health Month, Dr. Victoria Tseng joins Glaucoma Chats on April 8 to discuss the latest research on glaucoma disparities, cultural and healthcare barriers, and why early screening is critical to protecting vision. Register to ask your questions live. ↘️

Register for Glaucoma Chats

Register for Glaucoma Chats Join us for a series of free monthly telephone discussions from National Glaucoma Research, a program of BrightFocus Foundation, featuring glaucoma specialists and other eye care professionals who discuss various aspects of l...

brightfocus.org

#BreakingNews from #ADPD2026: New treatment approaches to address unmet needs for people living with Alzheimer’s. Read about promising data on a pill-based treatment, risk-reducing lifestyle changes effective a decade later, and other top stories: https://bit.ly/4bRwFSi

Join today’s episode of Zoom In on Dementia & Alzheimer’s to explore the early #Alzheimers symptoms to watch for, other medical issues that may look like dementia, and why early conversations with your doctor matter. Watch live at 1 p.m. today: https://www.youtube.com/live/LF1arJTrzes

Is It Alzheimer’s? Recognizing Early Signs & Symptoms

YouTube video by BrightFocus Foundation

youtube.com

Top questions from people living with macular degeneration will be answered live today at 1 p.m. ET! Join BrightFocus Foundation's #MacularChat for a real-time Q&A with ophthalmologist Dr. Joshua Dunaief. 🔗 Listen live now: BrightFocus.org/livechatMDR

Macular Chats - Live Audio Stream

Tune into live audio sessions with vision experts discussing macular degeneration care, treatment, and patient questions.

brightfocus.org

We're hosting an interactive Macular Chat on March 25 where we'll answer your top questions about age-related macular degeneration (AMD). We’ll cover everything from the different types of AMD to nutrition, supplements, daily living tips, and treatment options. Register now: https://bit.ly/4rxnNHr

Macular Chats - Live Audio Stream

Tune into live audio sessions with vision experts discussing macular degeneration care, treatment, and patient questions.

bit.ly

Look inside the hippocampus: where memories are made! The blue shows myelin, a protective coating on brain "wires" (axons) that speeds up messages between neurons. Dr. Isabelle Aubert is developing a therapy using noninvasive ultrasound waves that may boost myelin production. https://bit.ly/4rkP9Bk

Join Dr. Inas Aboobakar of Mass. Eye and Ear today, March 11 at 1pm ET, as she explains the role of genetics and family history in glaucoma as well as what and when to share with relatives, and how to encourage glaucoma eye exams. 🎧 Listen live: https://bit.ly/4nz3KGw

Join Dr. Inas Aboobakar of Mass. Eye and Ear today, March 11 at 1pm ET, as she explains the role of genetics and family history in glaucoma as well as what and when to share with relatives, and how to encourage glaucoma eye exams. 🎧 Listen live: https://bit.ly/4nz3KGw

On March 26, neurologist Dr. Sharon Cohen joins us to walk through the early signs of Alzheimer's, the conditions that can look like dementia but aren't, and how to have a productive conversation with your doctor. Bring your questions. Register to join live: https://bit.ly/4qhsHsO

Register for Zoom In On Dementia & Alzheimer's

Learn about Alzheimer's and dementia treatments, risk reduction, and more during this free virtual discussion series with world-class expert research scientists.

bit.ly

In 2025, 182 clinical trials evaluated 138 experimental drugs, reflecting real momentum in how scientists understand the biology, genetics, and biomarkers driving this disease. Learn how that progress is translating into new ways to treat the disease. 🔴 WATCH LIVE TODAY: https://bit.ly/4aR3j7l

Alzheimer’s Clinical Trials 2026: An Insider’s Look with Dr. Jeffrey Cummings

YouTube video by BrightFocus Foundation

youtube.com

Family history is one of the strongest risk factors for glaucoma. Dr. Inas Aboobakar joins Glaucoma Chats to explain the role of genetics and family history in glaucoma, what and when to share with relatives, and how to encourage glaucoma eye exams. Register: https://bit.ly/4u7l1Lh

From disease-modifying therapies and oral pills to non-pharmacological options, the Alzheimer’s treatment pipeline includes a wider range of approaches than ever before. Read about what’s to come in 2026 and beyond: https://bit.ly/4aMpGcS.

Check out these stunning brain cells derived from a person with Alzheimer’s disease. • Green = Young • Red = Mature Dr. Josephy Herdy is using these stem cells to study how to stop brain inflammation in Alzheimer’s disease. Explore the research: https://bit.ly/3OqvJfz

Early-stage AMD often has no symptoms. By the time people notice vision changes, the disease may have already progressed. That's why Paul, a stand-up comedian living with AMD, recommends comprehensive eye exams for everyone over 40, even if your vision seems fine. https://bit.ly/49L8K7n.